PharmaVoice provides industry news and insights related to the pharmaceutical sector, focusing on voices and opinions from industry leaders and covering various topics such as biotech, commercialization, and policy.

PharmaVoice

PharmaVoice | 12,272 followers on LinkedIn. Covering everything from Molecule to Market | PharmaVoice is for life-sciences executives and other healthcare-service related professionals. 

The primary audience is made up of executive and corporate management from pharmaceutical, biotechnology, drug delivery, marketing communications, clinical services, contract research, drug development, and information technology companies, as well as other industry sectors. Additionally, PharmaVoice.com has readers from around the world.

CEO, MANA RBM

Penelope Manasco, M.D.

Senior Writer & Editor at PharmaVoice

Michael Gibney

Homeopathic Consultant at PharmaVoice

Esma Sid

Marketing Program Manager at PharmaVoice

Amy Bishop

Stay informed with the latest pharma industry news and insights by signing up for PharmaVoice. Explore all our free newsletter options here: https://lnkd.in/gP2m_c7J

After being abandoned by Big Pharma, psychiatric drug development is undergoing a renaissance with researchers throwing scientific weight behind a range of new targets. “The more we can refine our population and target them with a precise mechanism, that is the best way,” says Dr. Husseini Manji, M.D., F.R.C.P.C. , adjunct professor of psychiatry at Yale University and former global therapeutic head of neuroscience at Johnson & Johnson . #spravato https://lnkd.in/e6c9KTVD

After multiple rejections, Lexicon Pharmaceuticals, Inc. is inching toward an FDA decision date next month for its adjunct type 1 diabetes therapy. https://lnkd.in/eGtmGFaD

Sernova ’s technology, dubbed the “Cell Pouch System,” helped type 1 diabetes patients achieve insulin independence in early- and mid-stage trials. “We believe this is a world’s first. We believe nobody else has achieved this,” says Sernova CEO Jonathan Rigby . #diabetes #biotech https://lnkd.in/eCEXujkG

Rallybio , a biotech with an early-stage candidate for the rare fetal and neonatal alloimmune thrombocytopenia, is headed into a mid-stage trial with enough cash through 2026, but the cyclical market has made the journey difficult. “The only currency a biotech company has is the story they tell,” says Dr. Stephen Uden , CEO and co-founder of Rallybio. #biotech #vc https://lnkd.in/eRBvVAnb

Epstein-Barr virus often lurks silently without triggering any symptoms, but the ubiquitous pathogen is everywhere. “Once you’re infected, it lives in your body. You never get rid of it,” says Dr. Andreas Muehler , chief medical officer at Immunic Therapeutics . Now, efforts to better understand EBV and make headway against the virus in pharma are ramping up. https://lnkd.in/erDa7F2g

Last month, Pfizer announced plans to yank its sickle cell drug Oxbryta from the market over safety concerns, leaving patients with one less treatment and unanswered questions. And despite the approval of one-and-done gene therapies from CRISPR Therapeutics / Vertex Pharmaceuticals and bluebird bio , patients still face unmet needs, analysts say. "This is a profoundly devastating disease," says Dr. Cameron Trenor, MD , head of translational medicine for Cellarity . #sicklecelldisease #genetherapy #celltherapy https://lnkd.in/ekQCDtZ5

Clinical trials are the heart of the pharma drug development process, and a successful trial design can make or break a drug’s outcome. Leaders in this space are partners for Big Pharma and biotech startups alike, striving to increase access for better enrollment, improve patient experiences and collect data that can deliver patient-centered goals. Check out this year's Clinical Trial Pros in the 2024 PharmaVoice 100! Barry Balfe , ICON plc Ben Casavant , Tasso, Inc. Samantha Eells, Lightship Sujay Jadhav , Verana Health Teri Karcher , Parexel Tina (Weldt) Karunaratne , Karuna Integrated Clinical Services Danielle S. Mitchell , Black Women In Clinical Research ® Dr. Beatrice S. , Altasciences Chanfeng Zhao , TriLink BioTechnologies, part of Maravai LifeSciences #clinicaltrials #clinicalresearch https://lnkd.in/eprSM4aT

Pfizer , Johnson & Johnson , Biogen and Novartis are banking on new products to make up for maturing blockbusters, but future growth is not guaranteed. https://lnkd.in/esCYvxMC

The explosion of gene and cell therapies is a testament to the dedication and steadfastness of the leaders pushing the envelope of what’s possible in biology. This year's Cell and Gene Therapy Pioneers in the 2024 PharmaVoice 100 class are spearheading a brand new facet of the industry and shaping its future. Dr. Eric Adler , Lexeo Therapeutics Dr. Aris Baras , Regeneron Bruce Lahn , VectorBuilder Benjamin Oakes , Scribe Therapeutics Nia Tatsis , Vertex Pharmaceuticals Joseph Truitt , iECURE, inc. Kristin Yarema, Ph.D. , Poseida Therapeutics, Inc. Heidi Zhang , Tune Therapeutics #celltherapy #genetherapy https://lnkd.in/eSu4wPKd

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 12, 2024 2:56 AM	ca3c0d87
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 12, 2024 2:56 AM	e307afce
crunchbase trigger	general	Nov 12, 2024 2:56 AM	822bfdc6
crunchbase profile	general	Nov 12, 2024 10:57 AM	e4d3f045
li profile	general	Nov 12, 2024 2:56 AM	013d12fc
translate crunchbase fundingrounds	general
peers	general	Nov 12, 2024 2:56 AM	58cf56c7
news basic	general	Nov 12, 2024 2:56 AM	4f3c4111
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

PHAR

COM:PHARMAVOICE

PharmaVoice